mTORC1 Selective Nano‐Inhibitor by Disrupting the Lysosomal Arginine‐SLC38A9‐ mTORC1‐CDKs Axis for Precision Bladder Cancer Therapy
- Journal:
- Advanced Materials
- Published:
- Affiliations:
- 4
- Authors:
- 10
| Institutions | Authors | Share |
|---|---|---|
| Nanjing Normal University (NNU), China | 0.70 | |
| Xihua University (XHU), China | 0.10 | |
| Drum Tower Hospital, China | 0.10 | |
| Yancheng Institute of Technology (YCIT), China | 0.10 |